Clinical trial • Phase IV • Oncology

Oxaliplatin for Colon cancer | Colonic cancer stage III

Phase IV trial of Oxaliplatin for Colon cancer | Colonic cancer stage III. 160 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Colon cancer | Colonic cancer stage III
Trial Stage
Phase IV
Drug Modality
Small molecule

Key dates

Initial CTIS Submission Date
11-07-2024
First CTIS Authorization Date
22-08-2024

Trial design

Phase IV trial across 22 sites in France.

Target Sample Size
160

Eligibility

Recruits 160 No vulnerable population selected (isVulnerablePopulationSelected: false).

Vulnerable Population
No vulnerable population selected (isVulnerablePopulationSelected: false)

Recruitment

Planned Sample Size
160
Recruitment Window Months
91

Geography

Total Number Of Sites
22
Total Number Of Participants
160

France

Earliest CTIS Part Ii Submission Date
11-07-2024
Latest Decision Or Authorization Date
22-08-2024
Processing Time Days
42
Number Of Sites
22
Number Of Participants
160

Sites

Site Name
Groupe Hospitalier Rance Emeraude
Department Name
oncology department
Contact Person Name
Romain Desgrippes
Contact Person Email
r.desgrippes@ch-stmalo.fr
Site Name
Centre Hospitalier Annecy Genevois
Department Name
oncology department
Contact Person Name
Emmanuel Maillard
Contact Person Email
emaillard@ch-annecygenevois.fr
Site Name
Institut Godinot
Department Name
oncology department
Contact Person Name
Damien Botsain
Site Name
Centre De Lutte Contre Le Cancer Eugene Marquis
Department Name
oncology department
Contact Person Name
Astrid Lievre
Contact Person Email
astrid.lievre@chu-rennes.fr
Site Name
Institut De Cancerologie Strasbourg Europe
Department Name
oncology department
Contact Person Name
Meher Ben Abdelghani
Site Name
Centre Hospitalier Regional Universitaire De Tours
Department Name
oncology department
Contact Person Name
Thierry Lecomte
Site Name
CHRU De Nancy
Department Name
oncology department
Contact Person Name
Anthony Lopez
Contact Person Email
a.lopez@chru-nancy.fr
Site Name
Centre Hospitalier De La Cote Basque
Department Name
oncology department
Contact Person Name
Franck Audemar
Contact Person Email
faudemar@ch-cotebasque.fr
Site Name
Clinique Pasteur Lanroze
Department Name
oncology department
Contact Person Name
Veronique Jestin le tallec
Site Name
Institut Regional Du Cancer De Montpellier
Department Name
oncology department
Contact Person Name
Eric assenat
Contact Person Email
eric.assenat@icm.unicancer.fr
Site Name
Centre Hospitalier Regional De Marseille
Department Name
oncology department
Contact Person Name
laetitia dahan
Contact Person Email
laeitita.dahan@ap-hm.fr
Site Name
Polyclinique Bordeaux Nord Aquitaine
Department Name
oncology department
Contact Person Name
Cedric Lecaille
Contact Person Email
lecail@hotmail.com
Site Name
Centre Hospitalier Universitaire De Dijon
Department Name
oncology department
Contact Person Name
Antoine Drouillard
Site Name
Centre Hospitalier Departemental Vendee
Department Name
oncology department
Contact Person Name
Lucile Bauguion
Contact Person Email
lucile.bauguion@chd-vendee.fr
Site Name
Centre Francois Baclesse
Department Name
oncol
Contact Person Name
Marie-Pierre Gallais
Contact Person Email
MPGALAIS@baclesse.unicancer.fr
Site Name
Centre Hospitalier De Perpignan
Department Name
oncology department
Contact Person Name
Faiza Khemissa
Contact Person Email
faiza.khemissa@ch-perpignan.fr
Site Name
Hopital Saint Joseph
Department Name
oncology department
Contact Person Name
Hervé Perrier
Contact Person Email
herve.perrier@wanadoo.fr
Site Name
Hopital Europeen Marseille
Department Name
oncology department
Contact Person Name
Yves Rinaldi
Contact Person Email
y.rinaldi@hopital-europeen.fr
Site Name
Hopital Saint Louis
Department Name
oncology department
Contact Person Name
Thomas Aparicio
Contact Person Email
thomas.aparicio@aphp.fr
Site Name
Centre Hospitalier Universitaire De Montpellier
Department Name
oncology department
Contact Person Name
Eric Assenat
Contact Person Email
e-assenat@chu-montpellier.fr
Site Name
Institut De Cancerologie De Lorraine
Department Name
oncology department
Contact Person Name
Aurélien Lambert
Contact Person Email
a.lambert@nancy.unicancer.fr
Site Name
CHU De Martinique
Department Name
oncology department
Contact Person Name
Cristina Furtos

Sponsor

Primary sponsor

Full Name
Institut Regional Du Cancer De Montpellier
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Investigational products

Investigational Product Name
Oxaliplatin
Active Substance
Oxaliplatin
Modality
Small molecule

Related trials

Other published trials that may interest you.